Show
Sort by
-
Sequential administration of low dose 5-azacytidine (AZA) and donor lymphocyte infusion (DLI) for patients with acute myeloid leukemia (AML) or myelodysplastic syndrome (MDS) in relapse after allogeneic stem cell transplantation (SCT) : a prospective study from the Belgian Hematology Society (BHS)
-
Use of chimerism analysis after allogeneic stem cell transplantation : Belgian guidelines and review of the current literature
-
- Journal Article
- A1
- open access
Clinical outcomes in patients with Philadelphia chromosome-positive leukemia treated with ponatinib in routine clinical practice-data from a Belgian registry
-
- Journal Article
- A1
- open access
Chimeric antigen receptor-T-cell therapy for B-cell hematological malignancies : an update of the pivotal clinical trial data
-
Results from the phase I clinical studies evaluating Cyad-01, a first-generation NKG2D CAR T-cell product in relapsed or refractory acute myeloid leukemia and myelodysplastic syndrome patients
-
- Conference Paper
- C3
- open access
Interim results from the phase I DEPLETHINK trial evaluating the infusion of a NKG2D CAR T-cell therapy post a non-myeloablative conditioning in relapse or refractory acute myeloid leukemia and myelodysplastic syndrome patients
-
- Conference Paper
- C3
- open access
Results from the completed dose-escalation of the hematological arm of the Phase I Think Study evaluating multiple infusions of NKG2D-based CAR T-cells as standalone therapy in relapse/refractory acute myeloid leukemia and myelodysplastic syndrome patients
-
Interruption or discontinuation of tyrosine kinase inhibitor treatment in chronic myeloid leukaemia : a retrospective cohort study (SPARKLE) in Belgium
-
A national multi-center randomized study to assess the accuracy, reliability, and user satisfaction of the Ebmt GvHD App in graft versus host disease assessment
-
Remissions in relapse/refractory acute myeloid leukemia patients following treatment with NKG2D CAR-T therapy without a prior preconditioning chemotherapy